Big pharma turns to AI to speed drug discovery, GSK signs deal

LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million (£33 million) deal in the field on Sunday.

from Reuters: Top News http://uk.reuters.com/article/uk-pharmaceuticals-ai-gsk-idUKKBN19N001?feedType=RSS&feedName=topNews